Effect of Mipomersen in Severe Hypercholesterolemia Version 1.0

  • Research type

    Research Study

  • Full title

    A Prospective Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen in Patients with Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and who are not on Apheresis

  • IRAS ID

    14935

  • Contact name

    Gordon Ferns

  • Contact email

    G.Ferns@surrey.ac.uk

  • Sponsor organisation

    Genzyme Corporation

  • Eudract number

    2008-006020-53

  • ISRCTN Number

    N/A

  • Clinicaltrials.gov Identifier

    NCT00794664

  • Research summary

    Research Summary not published at request of researcher

  • REC name

    London - Dulwich Research Ethics Committee

  • REC reference

    09/H0808/12

  • Date of REC Opinion

    17 Apr 2009

  • REC opinion

    Further Information Favourable Opinion